Ventus Therapeutics rallies $140m Series C
Ventus Therapeutics, Inc., a biopharmaceutical company, has raised $140 million in Series C financing.
Ventus Therapeutics, Inc., a biopharmaceutical company, has raised $140 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination